M. Patel

Breast irradiation postlumpectomy: development and evaluation of a decision instrument.

Timothy J. Whelan, Mark N. Levine, Amiram Gafni et al. · Journal of Clinical Oncology · 1995 · 118 citations

Medicine, Oncology, Radiation Oncology +17

Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels.

William U. Shipley, Daniel Hunt, Himanshu Lukka et al. · Journal of Clinical Oncology · 2011 · 65 citations

Medicine, Oncology, Radiation Oncology +17

Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels

William U. Shipley, Daniel Hunt, Himanshu Lukka et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 48 citations · Full text

Medicine, Oncology, Urology +17

Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)

Jeff M. Michalski, Jennifer Moughan, James A. Purdy et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 38 citations

Medicine, Radiation Oncology, Urology +13

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

William U. Shipley, Wendy Seiferheld, Himu Lukka et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 23 citations

Medicine, Oncology, Urology +17